Home > Events > Educational > Webinars > webinars EURO-NMD > Oligonucleotide therapies: a new class of drugs that allow precise genetic targeting
A A A

Oligonucleotide therapies: a new class of drugs that allow precise genetic targeting

19 Oct 2021

Online

Delivered by Annemieke Aartsma-Rus on 19th october 3-4pm CEST
The speaker is Professor of Translational Genetics at the Department of Human Genetics at the Leiden University Medical Center in the Netherlands. She has an interest on the development of antisense oligo nucleotides treatments, namely for Duchenne muscular dystrophy.